Brian E. Mcdowell

Array ( [id] => 5546706 [patent_doc_number] => 20090156583 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Tricyclic Amide Derivatives' [patent_app_type] => utility [patent_app_number] => 12/389619 [patent_app_country] => US [patent_app_date] => 2009-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27011 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20090156583.pdf [firstpage_image] =>[orig_patent_app_number] => 12389619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9216469 [patent_doc_number] => 08629269 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-14 [patent_title] => 'Dye for a dye-sensitised solar cell, and a solar cell comprising the same' [patent_app_type] => utility [patent_app_number] => 12/866347 [patent_app_country] => US [patent_app_date] => 2009-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 19 [patent_no_of_words] => 12968 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12866347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5304155 [patent_doc_number] => 20090298807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'Compounds' [patent_app_type] => utility [patent_app_number] => 12/365570 [patent_app_country] => US [patent_app_date] => 2009-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 174590 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298807.pdf [firstpage_image] =>[orig_patent_app_number] => 12365570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5986789 [patent_doc_number] => 20110098262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'CORROLES FOR NEUROPROTECTION AND NEURORESCUE' [patent_app_type] => utility [patent_app_number] => 12/865793 [patent_app_country] => US [patent_app_date] => 2009-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 19385 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20110098262.pdf [firstpage_image] =>[orig_patent_app_number] => 12865793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6353940 [patent_doc_number] => 20100331540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'METHOD FOR PRODUCING COMPOUND HAVING DEUTERATED AROMATIC RING OR HETEROCYCLIC RING' [patent_app_type] => utility [patent_app_number] => 12/865240 [patent_app_country] => US [patent_app_date] => 2009-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8658 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0331/20100331540.pdf [firstpage_image] =>[orig_patent_app_number] => 12865240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5580506 [patent_doc_number] => 20090175852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'IMIDAZOPYRAZINES AS PROTEIN KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/362367 [patent_app_country] => US [patent_app_date] => 2009-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15750 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20090175852.pdf [firstpage_image] =>[orig_patent_app_number] => 12362367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5987210 [patent_doc_number] => 20110098310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'NOVEL COMPOUNDS, USE AND PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 12/865359 [patent_app_country] => US [patent_app_date] => 2009-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12594 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20110098310.pdf [firstpage_image] =>[orig_patent_app_number] => 12865359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8024175 [patent_doc_number] => RE043274 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2012-03-27 [patent_title] => 'Fluorinated photosensitizers related to chlorins and bacteriochlorins for photodynamic therapy' [patent_app_type] => reissue [patent_app_number] => 12/321729 [patent_app_country] => US [patent_app_date] => 2009-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 18 [patent_no_of_words] => 27163 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/043/RE043274.pdf [firstpage_image] =>[orig_patent_app_number] => 12321729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5993557 [patent_doc_number] => 20110015210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes' [patent_app_type] => utility [patent_app_number] => 12/920932 [patent_app_country] => US [patent_app_date] => 2009-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11152 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20110015210.pdf [firstpage_image] =>[orig_patent_app_number] => 12920932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8629950 [patent_doc_number] => 08362022 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-29 [patent_title] => 'Selective subtype alpha 2 adrenergic agents and methods for use thereof' [patent_app_type] => utility [patent_app_number] => 12/811773 [patent_app_country] => US [patent_app_date] => 2009-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14975 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12811773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8591970 [patent_doc_number] => 08349846 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-08 [patent_title] => 'Fused pyrimidine derivatives as TRPV3 modulators' [patent_app_type] => utility [patent_app_number] => 12/811975 [patent_app_country] => US [patent_app_date] => 2009-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18003 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12811975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9020500 [patent_doc_number] => 08530486 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-10 [patent_title] => 'Quinazolines and related heterocyclic compounds, and their therapeutic use' [patent_app_type] => utility [patent_app_number] => 12/811547 [patent_app_country] => US [patent_app_date] => 2009-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11488 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12811547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6633900 [patent_doc_number] => 20100311965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => '2-AMINOQUINAZOLINE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 12/810386 [patent_app_country] => US [patent_app_date] => 2008-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41290 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311965.pdf [firstpage_image] =>[orig_patent_app_number] => 12810386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8909689 [patent_doc_number] => 08481753 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'Method for producing isoindole' [patent_app_type] => utility [patent_app_number] => 12/864618 [patent_app_country] => US [patent_app_date] => 2008-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14100 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12864618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 71900 [patent_doc_number] => 07754729 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-13 [patent_title] => 'Quinazoline and quinoline derivatives as irreversible protein tyrosine kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/342104 [patent_app_country] => US [patent_app_date] => 2008-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17536 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/754/07754729.pdf [firstpage_image] =>[orig_patent_app_number] => 12342104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6267063 [patent_doc_number] => 20100298324 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'Prolyl Hydroxylase Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/808195 [patent_app_country] => US [patent_app_date] => 2008-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46890 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298324.pdf [firstpage_image] =>[orig_patent_app_number] => 12808195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11297755 [patent_doc_number] => 09505750 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-29 [patent_title] => '5-aminocyclylmethyl-oxazolidin-2-one derivatives' [patent_app_type] => utility [patent_app_number] => 12/809555 [patent_app_country] => US [patent_app_date] => 2008-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28151 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12809555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6187079 [patent_doc_number] => 20110124867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'Process and intermediates for the Synthesis of heterocyclic Substituted Piperazines with CXCR3 Antagonist Activity' [patent_app_type] => utility [patent_app_number] => 12/809101 [patent_app_country] => US [patent_app_date] => 2008-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8188 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20110124867.pdf [firstpage_image] =>[orig_patent_app_number] => 12809101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6275718 [patent_doc_number] => 20100256129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/734993 [patent_app_country] => US [patent_app_date] => 2008-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 68125 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20100256129.pdf [firstpage_image] =>[orig_patent_app_number] => 12734993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6275718 [patent_doc_number] => 20100256129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/734993 [patent_app_country] => US [patent_app_date] => 2008-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 68125 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20100256129.pdf [firstpage_image] =>[orig_patent_app_number] => 12734993 [rel_patent_id] =>[rel_patent_doc_number] =>)